Editing CAR T cells to produce inflammatory cytokines helps them enter solid tumors and promote cancer killing.

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.

Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...

Autoimmune diseases arise when the immune system mistakenly targets and damages the body’s cells and tissues as though they ...

For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its ...

Scientists are developing a "sponge" that can soak up pain signals in the body before they reach the brain, potentially ...

The FDA's breakthrough therapy designation facilitates accelerated development and regulatory review for therapies showing ...

A new OHSU study shows how the immune system can quietly disrupt brain function — and why the disease is often hard to ...

Explore the complexities of modern oncology, including precision medicine, CAR T-cell therapies, and challenges in breast ...

Let’s say it’s 2036, and scientists are working on a new class of drugs. Today, for instance, pharmaceutical companies use ...

CAR031's global reach," including in China, as a potential treatment for liver and other solid tumors, AbelZeta CEO Tony Liu said.

That’s only one problem. Your immune system also has an adaptive system of specialized immune cells and antibodies that attack and destroy invading microbes. This system remembers what those intruders ...